Ovodan Biotech A/S: Financial statements 2025
CVR: 33870256
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Ovodan Biotech A/S (CVR 33870256) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -805,830 and a net result of DKK -1,201,387 compared with DKK -1,177,651 the year before. Equity in the 2025 report amounted to DKK -884,888. The company had 2 employees in the financial year.
- Gross Profit
- DKK -805,830
- Profit/Loss
- DKK -1,201,387
- Equity
- DKK -884,888
- Total Assets
- DKK 1,379,210
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -806K | -1.2M | -885K | 2 |
| 2024 | - | -313K | -1.2M | 316K | 2 |
| 2023 | - | -157K | 221K | -20.5M | 2 |
| 2022 | - | -439K | -1.5M | -20.7M | 3 |
| 2021 | - | -741K | -2M | -19.2M | 3 |
Official annual report
How creditworthy is Ovodan Biotech A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Ovodan Biotech A/S has published its annual report for 2024. Gross profit came to DKK -312,560, and the net result was DKK -1,177,651.
About Ovodan Biotech A/S
Ovodan Biotech A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SANOVO BIOTECH A/S. The management consists of Henrik Marinus Pedersen. The board consists of Thor Stadil (chair), Christian Nicholas Rosenkrantz Stadil and Henrik Marinus Pedersen. The company is owned by Ovodan Foods A/S. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -805,830 and a net result of DKK -1,201,387 compared with DKK -1,177,651 the year before. Equity in the 2025 report amounted to DKK -884,888.